Mirae Asset Global Etfs Holdings Ltd. Tenaya Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 22,778 shares of TNYA stock, worth $62,867. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,778Holding current value
$62,867% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TNYA
# of Institutions
99Shares Held
56MCall Options Held
30.3KPut Options Held
600-
Column Group LLC San Francisco, CA9.4MShares$25.9 Million40.92% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.62MShares$21 Million0.36% of portfolio
-
Casdin Capital, LLC New York, NY6.73MShares$18.6 Million1.8% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$11.2 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.51MShares$9.7 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $114M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...